CEN Biotech   Report issue

For profit
Founded: Windsor Canada (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2015
NCT03545399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CEN Biotech | CEN Experimental | CEN Nutriment

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 7
  • # of Trial APIs: 9